effect of Ayurvedic intervention in COVID-19 positive cases

A Pilot study to estimate the effectiveness of Ayurvedic intervention in COVID-19 positive cases

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/05/025276

Enrollment

Registered

2020-05-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Ayurvedic medicines: 1. Sanshamani Vati (Tinospora cordifolia) 1gm BD with 50ml Nagaradi kwath(Decoction of Zingiber officinale -2 part, Terminalia chebula- 4 part, Tinospora cordif

Eligibility

Inclusion criteria

Inclusion criteria: 1. Willingness to participate in the study and provide the informed consent. 2. Isolated asymptomatic cases that have been tested positive for SARS-CoV2 virus.

Exclusion criteria

Exclusion criteria: 1. Cases presenting with severe symptoms of COVID-19. 2. COVID-19 positive cases participating as subjects in the interventional arm of other COVID-19 clinical study.

Design outcomes

Primary

Measure	Time frame
1. Time taken and number of patients progressing from asymptomatic to symptomatic condition. Timepoint: baseline Daily 14 days	—

Secondary

Measure	Time frame
Time taken to negative conversion of RT-PCR Timepoint: Baseline 10th day 15th day	—

Countries

India

Contacts

Public ContactDr Arun Gupta

Chaudhary Brahm Prakash Ayurved Charak Sansthan

arun24@hotmail.com9999155377

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026